Liquid biopsy enhances MRI studies of breast cancer patients
Adding a liquid biopsy to MRI may improve the ability to gauge breast cance...Read more on AuntMinnie.comRelated Reading: The future of cancer screening could include blood test MRI, blood tests could guide care for glioblastoma ISMRM: Personalized breast cancer screening is at hand Liquid biopsy can be game-changer in radiology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 10, 2021 Category: Radiology Source Type: news

COVID-19 has had dramatic impact on breast imaging
COVID-19 has dramatically impacted breast imaging by delaying screening exam...Read more on AuntMinnie.comRelated Reading: SBI releases reopening plan for breast imaging facilities Who gets breast cancer treatment during a pandemic? SBI releases coronavirus social distancing tips SBI cancels April symposium due to coronavirus ACR, SBI rebuff new breast cancer screening guidelines (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 9, 2021 Category: Radiology Source Type: news

Cuzick: It's time to think about risk-adapted breast cancer screening
It's time to consider risk-adapted breast cancer screening, said Jack Cuzick...Read more on AuntMinnie.comRelated Reading: Health practitioners overestimate likelihood of disease, study says Breast cancer incidence to increase by 2040, but not mortality DBT shows promise in new study with lower interval cancer rates Is media coverage of mammography biased toward optimism? Breast screening rates rebound after COVID, but deficit remains (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 9, 2021 Category: Radiology Source Type: news

Can HER2-Positive Breast Cancer Be Cured?
Title: Can HER2-Positive Breast Cancer Be Cured?Category: Diseases and ConditionsCreated: 4/9/2021 12:00:00 AMLast Editorial Review: 4/9/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 9, 2021 Category: Cancer & Oncology Source Type: news

National nonprofits launch cancer screening campaign in COVID-19 era
The Community Oncology Alliance and CancerCare, two national nonprofit advocac...Read more on AuntMinnie.comRelated Reading: Breast cancer incidence to increase by 2040, but not mortality How can access to CT lung cancer screening be improved? ASTRO survey finds rise in advanced-stage cancer CT exam encounters could boost colorectal cancer screening Cancer screenings drop precipitously due to COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 8, 2021 Category: Radiology Source Type: news

Changes in Cancer Incidence, Deaths Expected by 2040
THURSDAY, April 8, 2021 -- Cancer incidence and death are expected to change by 2040, with breast cancer remaining the most common cancer followed by melanoma, then lung cancer, according to a study published online April 7 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2021 Category: Pharmaceuticals Source Type: news

Health practitioners overestimate likelihood of disease, study says
Most medical practitioners overestimate how likely patients are to have disease...Read more on AuntMinnie.comRelated Reading: Breast cancer incidence to increase by 2040, but not mortality FDG-PET/CT effective for staging in new breast cancer Researchers evaluate deep learning for breast ultrasound Daily chest x-rays not needed in COVID-19 patients AI, quantitative CT helps shed light on COVID-19 progression (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 8, 2021 Category: Radiology Source Type: news

Configuring infrared spectroscopy tools to better detect breast cancer
(Beckman Institute for Advanced Science and Technology) Researchers at the Beckman Institute for Advanced Science and Technology are one step closer to outlining the most efficient and effective methods of using breast cancer detection tools. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 8, 2021 Category: Cancer & Oncology Source Type: news

FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer
FDA granted regular approval to sacituzumab govitecan (Trodelvy, Immunomedics Inc.) for patients with unresectable locally advanced or metastatic triple-negative breast cancer who have received two or more prior systemic therapies, at least one of them for metastatic disease. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 7, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Breast cancer incidence to increase by 2040, but not mortality
Breast cancer incidence will likely grow over the next two decades in the U.S....Read more on AuntMinnie.comRelated Reading: Falling lung cancer rates drive cancer decline in U.S. Cancer caused 4M years of lost life in U.S. New treatments lead to drop in lung cancer deaths Medicaid expansion under ACA linked to fewer cancer deaths Cancer deaths decline in the U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 7, 2021 Category: Radiology Source Type: news

FDG-PET/CT effective for staging in new breast cancer
FDG-PET/CT scans are a valuable tool for staging women newly diagnosed wit...Read more on AuntMinnie.comRelated Reading: Keto diet improves PET/CT of cardiac sarcoidosis SNMMI provides update on COVID-19 vaccine and PET/CT FDG-PET/MRI offers option for pediatric Hodgkin lymphoma FDG-PET/CT shows COVID-19 vaccine uptake Is there a place for whole-body cancer screening? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 7, 2021 Category: Radiology Source Type: news

Roche launches Elecsys Anti-p53 immunoassay to aid diagnosis of various cancer types
Basel, 07 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys Anti-p53 immunoassay for the in vitro quantitative determination of anti-p53 antibodies. This test is used to aid physicians to diagnose throat cancer, bowel cancer and breast cancer in patients, in conjunction with other diagnostic tests. The assay is now available for all markets accepting the CE Mark.“The addition of our Elecsys Anti-p53 immunoassay will help clinicians to quickly and reliably diagnose several prevalent cancers and might assist in leading to a better prognosis for many patients.”, said Thomas ...
Source: Roche Media News - April 7, 2021 Category: Pharmaceuticals Source Type: news

Roche launches Elecsys Anti-p53 immunoassay to aid diagnosis of various cancer types
Basel, 07 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys Anti-p53 immunoassay for the in vitro quantitative determination of anti-p53 antibodies. This test is used to aid physicians to diagnose throat cancer, bowel cancer and breast cancer in patients, in conjunction with other diagnostic tests. The assay is now available for all markets accepting the CE Mark.“The addition of our Elecsys Anti-p53 immunoassay will help clinicians to quickly and reliably diagnose several prevalent cancers and might assist in leading to a better prognosis for many patients.”, said Thomas ...
Source: Roche Investor Update - April 7, 2021 Category: Pharmaceuticals Source Type: news

Fewer breast cancer cases between screening rounds with 3D-mammography
(Lund University) 3D-mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 7, 2021 Category: Cancer & Oncology Source Type: news

Surgical technique recommended for DCIS patients
New research suggests removing additional tissue around the tumor cavity fo...Read more on AuntMinnie.comRelated Reading: DBT shows promise in new study with lower interval cancer rates Breast screening rates rebound after COVID, but deficit remains Estrogen receptor tied to outcomes in DCIS PET aids in treatment of metastatic breast cancer patients Review supports surgical excision for FEA breast lesions (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news

Breast Cancer Centers Urge Annual Scans, Counter to U.S. Guidelines
A panel recommends biennial screenings, starting at 50, but a new study took issue with the way hundreds of centers are telling women 40 and up to come in yearly. Some experts contend that frequent mammograms can “do more harm than good.” (Source: NYT Health)
Source: NYT Health - April 6, 2021 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: Mammography Breast Cancer Women and Girls Tests (Medical) Preventive Medicine Research JAMA Internal Medicine (Journal) United States Preventive Services Task Force your-feed-healthcare Source Type: news

Breast cancer: New five-minute Phesgo treatment 'great'
Paula Lamb says being one of the first patients to receive the new treatment "feels amazing". (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 6, 2021 Category: Consumer Health News Source Type: news

Cancer discovery could revive failed treatments for solid tumors
(University of Virginia Health System) New research could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon and triple-negative breast cancer, that ultimately failed in human clinical trials. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 6, 2021 Category: Cancer & Oncology Source Type: news

Breast cancer survivors' fear of cancer returning linked to genomic testing, psychological factors
(New York University) Breast cancer survivors with a higher risk of cancer recurrence based on genomic testing may experience greater fear of their cancer returning, according to a new study led by researchers at NYU Rory Meyers College of Nursing. However, psychological factors such as anxiety are the best predictors of survivors' fear of their cancer recurring. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 6, 2021 Category: International Medicine & Public Health Source Type: news

Digital breast tomosynthesis reduces rate of interval cancers
(Radiological Society of North America) Screening with digital breast tomosynthesis (DBT) reduces the rate of interval breast cancers compared to screening with digital mammography, according to a new study. The study adds to a growing body of evidence supporting DBT as a breast cancer screening tool with important advantages over mammography. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 6, 2021 Category: Cancer & Oncology Source Type: news

Patients set to benefit from five-minute breast cancer treatment
An injection that cuts the amount of time breast cancer patients spend in hospital from two and a half hours to as little as five minutes is being rolled out across the country by NHS England. (Source: NHS Networks)
Source: NHS Networks - April 6, 2021 Category: UK Health Source Type: news

Is media coverage of mammography biased toward optimism?
New research published in JAMA Internal Medicine suggests that medi...Read more on AuntMinnie.comRelated Reading: Breast screening rates rebound after COVID, but deficit remains FDA issues mammography alert for Tenn. facility Risk analysis could help triage women for mammography Study claims breast centers flout mammography screening guidelines Breast cancer data may fuel debate on screening women over 75 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 5, 2021 Category: Radiology Source Type: news

Gala of Hope Foundation unveils new partnership with local charitable organization
A Beavercreek-based nonprofit foundation dedicated to cancer research has entered into a partnership with a local charitable organization. The Gala of Hope Foundation has begun managing the Living with Lymphedema fund, the organization announced Wednesday. Founded by Terri Baldasare, Living with Lymphedema provides compression garments for cancer survivors who cannot afford them. Baldasare, who lives in Centerville, developed lymphe dema in 2011 after undergoing treatment for breast cancer. Common… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 5, 2021 Category: Health Management Authors: Jacob Fisher Source Type: news

IceCure Medical Granted FDA Breakthrough Device Designation for ProSense(R) Cryoablation System
Treatment for patients with T1 invasive breast cancer and/or breast cancer for patients not suitable for surgical alternatives included in the indications being reviewed CAESAREA, Israel, April 5, 2021 -- (Healthcare Sales & Marketing Network) -- IceC... Devices, Oncology, FDA IceCure Medical, ProSense , cryoablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2021 Category: Pharmaceuticals Source Type: news

Going deep: Artificial intelligence improves accuracy of breast ultrasound diagnoses
(Cactus Communications) Ultrasound is widely used to detect breast cancer early, but misdiagnosis of benign lesions as malignant tumors sometimes leads to unnecessary biopsies. To tackle this problem, scientists conducted a large multi-center study involving 13 hospitals in China to train deep learning models to accurately classify breast masses. Their results, published in Chinese Medical Journal, showcase how artificial intelligence could find use as an assistive tool in ultrasound breast diagnosis and help alleviate workload of doctors. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 5, 2021 Category: Biology Source Type: news

Surgical technique may reduce positive margin rate in breast cancer patients with DCIS
(Wake Forest Baptist Medical Center) According to the American Cancer Society, a noninvasive breast cancer called ductal carcinoma in situ (DCIS) accounts for approximately one of every four new breast cancer cases in the United States. If left untreated, DCIS has the potential to evolve into invasive cancer, so many patients choose to have breast-conserving surgery or mastectomy after a diagnosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 5, 2021 Category: Cancer & Oncology Source Type: news

'A life-changer': NHS England rolls out five-minute breast cancer treatment
New ‘quicker and kinder’ treatment combining drugs cuts length of time some patients have to spend in hospitalA new breast cancer treatment will cut the amount of time some patients have to spend in hospital from two and a half hours to five minutes.The treatment, called Phesgo, is being rolled out across England by the NHS and will be offered to breast cancer patients undergoing chemotherapy. It will be available to people with HER2-positive breast cancer, which accounts for 15% of all such cancers.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 5, 2021 Category: Science Authors: PA Media Tags: Breast cancer NHS Health Society Source Type: news

DR ELLIE CANNON: Help! Sex is painful at 72 but I can't take HRT pills to cure it
DR ELLIE CANNON: Today our resident GP advises a reader in her 70s who suffers pain when having sex but cannot take HRT as she has a family history of breast cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2021 Category: Consumer Health News Source Type: news

Amanda Mealing recalls breast cancer diagnosis and fears she wouldn't see children grow up
AMANDA MEALING stars as Connie Beauchamp in the BBC One long-running drama Casualty. Away from the set, the 53-year-old had to keep returning to hospital when she was diagnosed with breast cancer in 2002. (Source: Daily Express - Health)
Source: Daily Express - Health - April 3, 2021 Category: Consumer Health News Source Type: news

Assessment of gait speed and timed up and go measures as predictors of falls in older breast cancer survivors - Blackwood J, Rybicki K.
BACKGROUND: Older breast cancer survivors are at an increased risk of loss of postural balance and accidental falls, however, the ability of clinical mobility measures to predict falls has not been determined. The purpose of this study was to examine the p... (Source: SafetyLit)
Source: SafetyLit - April 2, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Cancer symptoms: All 12 physical signs of breast cancer you can see or feel
BREAST cancer will affect one in seven women during their lifetime, meaning the chances of knowing someone who develops the disease is high. Knowing your body is key to identifying any changes that need a medical overview. (Source: Daily Express - Health)
Source: Daily Express - Health - April 2, 2021 Category: Consumer Health News Source Type: news

Breast screening rates rebound after COVID, but deficit remains
U.S. mammography screening rates have rebounded since plunging in the firs...Read more on AuntMinnie.comRelated Reading: Adenopathy may occur after COVID-19 vaccination Skipping mammograms boosts risk of breast cancer death COVID-19 vaccine affects imaging results, researchers warn How many cancers were missed during the COVID-19 pandemic? Patients in Canada missing recommended cancer screenings (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 2, 2021 Category: Radiology Source Type: news

Is Breast Cancer Metastatic Terminal?
Title: Is Breast Cancer Metastatic Terminal?Category: Diseases and ConditionsCreated: 4/2/2021 12:00:00 AMLast Editorial Review: 4/2/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 2, 2021 Category: Cancer & Oncology Source Type: news

Targeting microRNAs could unmask hidden vulnerability in breast cancer stem cells
(Rockefeller University Press) Researchers in Italy have identified a pair of microRNA molecules that help maintain a population of cancerous stem cells that drive the growth of breast cancers and initiate tumor relapse after treatment. The study, which will be published April 2 in the Journal of Cell Biology (JCB), reveals that targeting these microRNAs makes cancer stem cells more susceptible to some chemotherapies and could potentially improve the prognosis of patients with aggressive forms of breast cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 2, 2021 Category: Biology Source Type: news

Therapeutic resistance linked to softer tissue environment in breast cancer
(Rockefeller University Press) Researchers at the University of California, San Francisco, have discovered that aggressive, triple-negative breast cancers (TNBCs) can evade treatment by reorganizing and softening the collagen matrix that surrounds the cancer cells. The study, which will be published April 2 in the Journal of Experimental Medicine (JEM), shows that the softer matrix activates a signaling pathway that promotes the cancer cells' survival, and suggests that targeting this pathway could enhance the effectiveness of chemo- and radiotherapy in TNBC patients. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 2, 2021 Category: Biology Source Type: news

Radiomics AI algorithm differentiates sclerotic bone lesions
A radiomics-based machine-learning model can differentiate bone islands an...Read more on AuntMinnie.comRelated Reading: MRI radiomics can predict risk of breast cancer recurrence CCTA radiomics yields insights into nature of coronary artery disease AI, radiomics predicts prostate cancer recurrence Radiomics, AI can guide NSCLC treatment decisions CT radiomics classifies small nodules found in CT lung screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 1, 2021 Category: Radiology Source Type: news

Nigeria: Poor Quality Maternal Medicines - the Slippery Slope to Maternal Deaths in Nigeria
[Nigeria Health Watch] Balarabe Danladi Zakariya, a resident of Gabari, Kano State thinks he is jinxed and the reason is not far-fetched. He was married twice and lost both his wives in childbirth. His first marriage had a sweet beginning until his wife, Lami, died of breast cancer months after giving birth to their first child. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 1, 2021 Category: African Health Source Type: news

Potential new treatment strategy for breast cancer cells that have spread to the brain
(Massachusetts General Hospital) Access to fat is more limited in brain tissue than in other tissues in the body, and breast cancer cells that spread to the brain must increase their production of fatty acids, the building blocks of fat. In mice, blocking such cells' ability to synthesize fatty acids reduced breast tumor growth in the brain. The findings may be helpful for designing new treatments for patients whose cancer has spread to the brain. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2021 Category: Cancer & Oncology Source Type: news

Bariatric Surgery Tied to Reduced Breast Cancer Risk, Earlier Diagnosis Bariatric Surgery Tied to Reduced Breast Cancer Risk, Earlier Diagnosis
Women with obesity who undergo bariatric surgery may have a lower risk of breast cancer and get diagnosed at earlier stages when they do develop these malignancies, a recent meta-analysis and systematic review suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 31, 2021 Category: Surgery Tags: Diabetes & Endocrinology News Source Type: news

National study examines US mammography screening rates during COVID-19 pandemic
(University of Vermont) A new study looking at US mammography screening rates during the first five months of the pandemic found both a strong rebound in breast cancer screening rates and a concerning cumulative deficit in mammograms due to missed appointments, as well as uncovering disparities when looking at screening according to race. The study was released this week in the Journal of the National Cancer Institute. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 31, 2021 Category: International Medicine & Public Health Source Type: news

Invasive Lobular Carcinoma: The Importance of This Subtype Invasive Lobular Carcinoma: The Importance of This Subtype
Get up-to-date on the latest research that has advanced our understanding of the pathology and management of this common subtype of breast cancer.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

ctDNA for Progression on Fulvestrant in ER+ Breast Cancer ctDNA for Progression on Fulvestrant in ER+ Breast Cancer
Does ctDNA prove an effective indicator of early progression on fulvestrant therapy in patients with advanced ER+ breast cancer?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Tiny magnet could help patients avoid the need for second breast cancer surgery
Samantha Matthews, 48, a head of university admissions from Surrey, was one of the first to undergo the technique, as she tells Adrian Monti. (Source: the Mail online | Health)
Source: the Mail online | Health - March 30, 2021 Category: Consumer Health News Source Type: news

A cancerous connection for creatine
Obesity induces adipocytes to release creatine that is used by nearby breast cancer cells to fuel growth. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - March 30, 2021 Category: Science Authors: Wong, W. Tags: STKE Editors ' Choice Source Type: news

Phoenix Molecular Designs Appoints Biotech Powerhouse, Michael Varney, Ph.D., to its Advisory Board
SAN DIEGO, California and VANCOUVER, BC, March 29, 2021 -- (Healthcare Sales & Marketing Network) - Phoenix Molecular Designs (PhoenixMD), a company on a mission to help thousands of patients and their families battling triple negative breast cancer (TNBC... Biopharmaceuticals, Oncology, Personnel Phoenix Molecular Designs, triple negative breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2021 Category: Pharmaceuticals Source Type: news

Prognostic value of molecular classification in metastatic breast cancer confirmed
(University of Barcelona) In a study published in the Journal of Clinical Oncology, researchers from the Hospital Cl í nic-IDIBAPS, University of Barcelona and SOLTI showed the predictive capacity of the 4 molecular subtypes of breast cancer (Luminal A, Luminal B, HER2-enriched and Basal-like). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 29, 2021 Category: Cancer & Oncology Source Type: news

Analysis system for breast cancer diagnosis solves ‘blackbox algorithm’ problem
The system uses heatmaps to make AI decisions transparent to clinicians. (Source: mobihealthnews)
Source: mobihealthnews - March 29, 2021 Category: Information Technology Tags: AI, Analytics, Predictive analytics, Data and Information Source Type: news

Actor Rita Wilson Reflects on Surviving Cancer, COVID
Actor Rita Wilson expresses gratitude and takes nothing for granted as she reflects on surviving breast cancer and COVID-19. (Source: WebMD Health)
Source: WebMD Health - March 26, 2021 Category: Consumer Health News Source Type: news

Huge, Struggling Breast Cancer Screening Trial Gets Lifeline Huge, Struggling Breast Cancer Screening Trial Gets Lifeline
A controversial, big-budget breast cancer screening trial got a vote of confidence from a special working group of the NCI.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Jos é Baselga, Who Advanced Breast Cancer Treatments, Dies at 61
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at AstraZeneca. (Source: NYT Health)
Source: NYT Health - March 26, 2021 Category: Consumer Health News Authors: Katie Thomas Tags: Baselga, Jose Deaths (Obituaries) Cancer Breast Cancer Drugs (Pharmaceuticals) Research Herceptin (Drug) Conflicts of Interest AstraZeneca PLC Memorial Sloan-Kettering Cancer Center Source Type: news